☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Urothelial Carcinoma
BMS' Opdivo(nivolumab) Receives the US FDA's Approval for the Adjuvant Treatment of High-Risk Urothelial Carcinoma
August 23, 2021
AstraZeneca Collaborates with Junshi to Commercialize Toripalimab in China
March 2, 2021
Merck KGaA and Pfizer's Bavencio (avelumab) Receive the US FDA's Approval as a 1L Treatment for Locally Advanced or Metastatic Uro...
July 1, 2020
BeiGene's Tislelizumab Receives NMPA's Priority Review to sNDA for Urothelial Carcinoma in China
July 8, 2019
Johnson & Johnson's Balversa (erdafitinib) Receives FDA's Approval for Locally Advanced or Metastatic Urothelial Carcinoma wit...
April 12, 2019
Load more...
Back to Home